Compositions comprising SIA for the treatment of diabetes
US8426362B2 · kind B2 · utility
3Cited by
5References
34Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 7, 2009 |
| Grant date | Apr 23, 2013 |
| Priority date | — |
| Expiry date | Nov 13, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A supramolecular insulin assembly and supramolecular exendin-4 assembly, which is useful as a protein therapeutic agent for the treatment of metabolic disorders particularly diabetes. The supramolecular assemblies disclosed in the present invention consists of insoluble and aggregated oligomers the protein. The invention also provides pharmaceutical compositions comprising the supramolecular assembly.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.